The past 18 months has presented the generics and brand pharmaceutical industries with a dilemma unique to the US market: whether a partnership to launch and market a generic version of the brand's ...

JERUSALEM, Jan 28 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab reported strong quarterly results on Wednesday but forecast lower net profit and revenue in 2026 on a more than $1 ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Amy is an ACA and the CEO and founder ...

CORRECTION: An earlier version of this story said Health Canada had approved several generics for semaglutide. They have received several submissions for approval for ...

Khadija Khartit is a strategy, investment, and funding expert, and an educator of fintech and strategic finance in top universities. She has been an investor, entrepreneur, and advisor for more than ...